DermaSensor

09/04/2026

September is National Skin Care Awareness Month - a reminder to make skin health part of everyday care.

Daily maintenance, regular skin checks, and early attention to suspicious changes all matter.

Patients: check your skin and speak with your provider about anything new or changing.

Providers: see how DermaSensor can support skin cancer risk assessment at the point of care.

Learn more or find a provider at the link in bio.

09/03/2026

We’re proud to be recognized by CIO Bulletin as a Leading Company to Watch in 2026!

This recognition reflects our team’s continued commitment to advancing AI-powered skin health technology and expanding access to skin cancer risk detection at the point of care.

We’re grateful for this recognition and excited to continue building what’s next for skin health.

An AI-powered device helping physicians detect skin cancer at the point of care, with 96% sensitivity across all three common skin cancers. Request a demo.

09/02/2026

Expanding access. Advancing care.

We're proud to announce four new strategic partnerships that will help bring DermaSensor's AI-powered skin cancer technology to more healthcare providers across the United States.

From primary care and enterprise health systems to federal healthcare and national distribution, these collaborations represent another step toward making objective skin lesion evaluation more accessible where it's needed most.

Learn more at DermaSensor.com.

08/21/2026

DermaSensor is not an at-home device.

It is a medical device intended for use by physicians in clinical settings, designed to support clinical decision-making when assessing suspicious skin lesions.

The goal is not to replace providers. It is to give clinicians access to real-time, non-invasive technology that can help bring more confidence, efficiency, and clarity into the patient visit.

Have a mole, spot, or lesion you’re concerned about?

Ask your provider about DermaSensor or learn more at dermasensor.com.

08/21/2026

AI in skin cancer detection comes with a lot of questions.

The truth is, AI-powered tools are not meant to replace clinicians. They are designed to support them with additional information, real-time insights, and more confidence at the point of care.

DermaSensor helps providers assess suspicious skin lesions with non-invasive technology that fits into everyday clinical workflows.

Ready to see how it can support your practice?

Request a demo at dermasensor.com.

08/19/2026

Join us in congratulating Cody Simmons, CEO of DermaSensor, on being named a 2026 Titan 100 Honoree, recognizing Miami’s top CEOs and C-level executives.

Cody’s leadership continues to advance DermaSensor’s mission to expand access to AI-powered skin cancer technology and provide clinicians with innovative tools that support patient care.

We’re incredibly proud of this well-deserved recognition and grateful for our team and partners who continue to make our mission possible.

08/14/2026

Across three clinical studies, DermaSensor demonstrated strong performance in supporting skin cancer risk assessment, including 95.5% device sensitivity in both the DERM-SUCCESS validation study and the DERM-ASSESS III melanoma study.

For providers, this matters. The right technology can help support more confident assessments, timely referral decisions, and greater efficiency at the point of care.

DermaSensor is designed to support non-dermatologist physicians when evaluating suspicious lesions already assessed as concerning for skin cancer.

See the data. Understand the technology. Read the full study at dermasensor.com
Request a DermaSensor demo at dermasensor.com.

08/10/2026

Melanoma cases are expected to remain a serious concern in the U.S. this year.

The American Cancer Society estimates over 200,000 new melanoma cases, with more than 8,000 potentially fatal outcomes.

But early detection can make a major difference.

Know your skin. Pay attention to changing spots, new moles, or lesions that don’t heal.

Schedule a skin check and ask your provider about DermaSensor.

Find a provider near you at dermasensor.com

08/10/2026

“I never thought skin cancer could happen to me… until it did.”

After years in the South Florida sun, Max noticed a lesion that wouldn’t heal. His primary care physician used DermaSensor to support the assessment and referred him to a dermatologist, where he was diagnosed with basal cell carcinoma.

His story is a reminder that skin cancer doesn’t always look obvious, and timely assessment matters.

Don’t wait for a suspicious spot to get worse. Ask your provider about DermaSensor or find a DermaSensor physician near you at dermasensor.com.

08/07/2026

Join us on August 12 at 3:00 PM ET for the AAPC-accredited virtual webinar, Skin Assessments: Neoplasms of Unknown Behavior.

Presented by The Reimbursement Group (TRG) and sponsored by DermaSensor, this webinar will provide practical guidance on documenting and coding dermal neoplasms of uncertain behavior in primary care.

Attendees will learn how to apply appropriate diagnosis and procedure codes while aligning evaluations with payer requirements.

A valuable conversation for providers and practice teams looking to better navigate skin assessment documentation and reimbursement.

Click the link in bio to register and join the conversation .